AVEO Oncology
AVEO
#7214
Rank
A$0.72 B
Marketcap
A$20.96
Share price
0.00%
Change (1 day)
140.82%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$74.54 Million a decrease over its 2020 earnings that were of -A$49.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-45.32%
2021 -A$74.54 Million49.9%
2020 -A$49.73 Million-479.04%
2019 A$13.11 M-276.17%
2018 -A$7.45 Million-91.79%
2017 -A$90.72 Million142.38%
2016 -A$37.43 Million78.51%
2015 -A$20.97 Million-71.55%
2014 -A$73.7 Million-50.72%
2013 -A$0.15 Billion-4.88%
2012 -A$0.16 Billion-426.29%
2011 A$48.18 M-159.85%
2010 -A$80.52 Million35.33%
2009 -A$59.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$35.95 B-88,708.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.54 B-31,010.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.17 B-5,460.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.30 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.03 B-32,222.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.16 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA